1.Histological changes of blood vessels following intervention with alendronate in vascular calcificated rats
Chinese Journal of Tissue Engineering Research 2007;0(50):-
AIM:To observe the histopathological changes of vascular calcificated rats following intervention with alendronate,further more,to verify the therapeutic action of alendronate on angiosteosis.METHODS:Thirty Sprague Dawley rats were divided into the normal,Vitamin D3 and alendronate groups by random number table after feeding for 1 week.Rats in the Vitamin D3 and alendronate groups were lavaged with 250 000 U/(kg ?d) Vitamin D3 or iso-capacity of sodium chloride at 0,24,and 48 hours after model preparation.From the fourth day,rats in the alendronate group were treated with 0.9 mg/(kg ?d) alendronate.All rats were sacrificed at the end of 6 weeks,removed aorta and aortic arch.The pathological change was analyzed by hematoxylin-eosin staining.In addition,calcium contents of blood vessel were measured.Von Kossa staining,Image-Pro Plus 6.0 image analysis software were used to determine the ratio of calcified plaque,and detected the content of blood fat.RESULTS:There had calcified plaque in the vessel wall of aortic arch in the alendronate group,but the number was obvious smaller than and the necrosis area was significantly lower than that of the Vitamin D3 group.The calcium contents of blood vessel,ratio of calcificated area,as well as the concentration of total cholesterol was decreased compared with the Vitamin D3 group(P
2.Prostaglandin E_2 induces osteoblast bone formation in aged male rats
Chinese Journal of Geriatrics 2003;0(11):-
Objective To examine the early effects of prostaglandin E 2 (PGE 2 ) on cancellous bone in 20-month aged male rats. Methods PGE 2 was given to the aged rats for 10 and 30 days at dose of 3 mg?kg -1 d -1 respectively, while designing intact aged male rats as controls. After twice in vivo fluorochrome labeling, undecalcified longitudinal sections were subjected to analysis of bone histomorphometry. Results After 10 days treatment, osteoblast surface 〔(12.3?7.6)%〕 and osteoid surface 〔(20.4?7.2)%〕 were markedly increased than that of controls 〔(1.6?0.7)% and (4.3?1.7)%, P
3.Antitumor effects of losartan in EAC mice
Chinese Journal of Clinical Pharmacology and Therapeutics 2000;0(03):-
AIM: To study the antitumor e ff ects of losartan in EAC mice. METHODS: The inhibitory rates of t umor growth and the ratio of extending viability were observed in EAC mice in th ree groups given losartan, 5-FU and NS, respectively. RESULTS: Comparing with the control groups, the inhibition to tumor growth was 46.3 % in losartan ( 12.5 mg?kg -1 ) group. But losartan did not lengthen life time in EAC mice. The inhibition to tumor growth was was 31.5 % in 5-F U (5 mg?kg -1 ) group. CONCLUSION: Losartan can inhibit the tumor growth of EAC, but not lengthen life time of the animals.
4.Effect of Yupingfeng Extract on Bone Metabolism in Model Rats with Osteoporosis Induced by Cyclophosphamide
China Pharmacy 2007;0(33):-
OBJECTIVE:To study the effect of Yupingfeng(YPF)extract on Ca,P,Mg and hydroxyproline of bone in model rats with osteoporosis induced by cyclophosphamide(CP)and to discuss the preventive and therapeutic effect of YPF ext-ract on CP-induced osteoporosis.METHODS:A total of 40 rats were randomly divided into four groups:control group,CP group,YPF extract group,and calci?m carbonate + Vit D group.The rats were sacrificed at 15 days of experiment,and the levels of Mg,Ca,P and hydroxyproline of left femoral bone were determined.RESULTS:Compared with control group,levels of different index with CP group was significantly decreased;compared with CP group,levels of Ca,Mg,P and hydroxyproline of bone in rats treated with YPF extract were significantly increased.CONCLUSION:CP may induce decrease of levels of Ca,Mg,P and hydroxyproline of bone,however,on which YPF extract has preventive and therapeutic effect.
5.Progress in animal model of dermatitis and eczema
Zongyan XU ; Tie WU ; Zhihua WU
Chinese Journal of Clinical Pharmacology and Therapeutics 2004;0(07):-
Dermatitis and eczema are allergic relapsing inflammatory skin disorders. The precise mechanisms still are unclear. Experimental animal models are indispensable tools to study the pathogenic mechanisms and test novel therapy. A considerable number of mouse models have been proposed and used to study specific aspects of the disease. This paper summarizes the currently available animal models.
6.Morphology and Biochemical Parameters in Rats with D-galactose-induced Skin Ageing
Lijun SHI ; Tie WU ; Zhihua WU
Chinese Journal of Dermatology 1995;0(03):-
Objective To observe the changes of morphology and biochemical parameters in rats with D-galactose-induced skin ageing. Methods Twenty-six female and male rats were randomly divided into 2 groups. D-galactose group rats were injected subcutaneously with 120 mg?kg-1?d-1 of D-galactose everyday, whereas the control group with normal saline. The rats were sacrificed on days 100. The ageing-related biochemical parameters were detected in the blood and skin, and the cutaneous histopathology was observed. Epidermal thickness and area of elastic fibers were determined quantitatively with imaging analysis system. Results Epidermal thickness and content of elastic fibers were significantly lower in D-galactose group than those in the control group. The loose arrangement of collagen and elastic fibers was evident in D-galactose group. These features of the rats in D-galactose group were similar to those in the ageing skin of human beings. Compared with the control group, the levels of hydroxyproline decreased and malondialdehyde (MDA) increased in the skin of the D-galactose group. The activity of glutathione peroxidase (GSH-PX) and catalase (CAT) in the whole blood and that of superoxide dismutase (SOD) in erythrocytes were remarkably reduced in the D-galactose group as compared to the control group. Conclusions The rat models with skin ageing are established by subcutaneous injection of 120 mg?kg-1?d-1 of D-galactose once daily for 100 days. The changes of morphologic and biochemical parameters in these models are analogous to those in human skin ageing.
9.Prevention and treatment of glycyrrhizic acid for liver-fibrosis bone loss and its mechanism
Chinese Journal of Tissue Engineering Research 2005;9(7):217-219
BACKGROUND: Since chronic liver disorders are associated with bone loss commonly, it is very significant to probe into the prevention of such bone loss for the treatment of osteoporosis.OBJECTIVE: To study the mechanism of glycyrrhizic acid on prevention and treatment of bone loss induced by liver fibrosis in mice.DESIGN: Randomized and controlled study in which the experimental animals were taken as the objects.SETTING: Experimental animal center, central experimental room and pharmacological research room of a universityMATERIALS: The experiment was performed from January to September 2001. Forty common-grade PCR mice of either sex were employed, weighted varied from 20 to 22 g, provided by Experimental Animal Center of the Institution. According to mass-equivalence principle, 4 groups were randomized, named as control, model group, the treatment with colchicine group(CL group) and the treatment of glycyrrhizic acid group(GA group-) with 10 mice in each group.METHODS: Except the control group, in the model group, CL group and GA group, the subcutaneous injection with 400 g/L carbon tetrachloride prepared with peanut oil was given for 5 weeks to induce liver fibrosis in mice. Afterward, the treatment was applied with carbon-tetrachloride peanut-oil solution 10 mL/kg, colchicum autumnale solution 0. 1 g/kg and glycyrrhizic acid solution 0. 1 mg/kg successively. At the end of the experiment, the eyeball was extirpated for blood collection. The serum was separated to assay the various relevant biochemical indexes of liver injury, observe the changes in liver pathological tissues and measure bone calcium(Ca2+) content of femur and the contents of other bone trace elements as well as bone oxyproline hydroxyproline (Hyp).Effects of glycyrrhizic acid on the contents of bone trace elements in mice of every group.RESULTS: The levels of serum aspartate aminotransferase(AST) and alanine aminotransferase(ALT) in CL group and GA group were lower than those in the model group( P < 0. 01 ). The level of albumin and ratio between albumin and globulin in the model group were lower than those in CL group and GA group( P < 0.01, P < 0.05) . The content of bone calcium in CL group and GA group were lower than that in the control group ( P < 0. 05),but that was higher than the model group( P < 0.05) . The unit contents of copper(Cu2+ ), magnesium(Mg2+) and zinc(Zn2+) in the right femur of the model group were all higher than the control group ( P < 0.01 ), but the contents of those in GA group were not indicated significant differences compared with the control group ( P > 0.05 ). The liver pathological changes of mice in GA group were obviously milder compared with the model group ( P < 0.01 ) and it was shown with VG staining the severity of hyperplasia of liver collagenous fibers was remarkably milder compared with the model group( P < 0.01).CONCLUSION: The extractive solution of glycyrrhizic acid induces medical metabolic enzyme in the liver, enhances detoxification of liver, protects liver to maintain protein metabolic level and maintains the normal metabolism of bone to promote bone Ca2+ and balance between oxyproline hydroxyproline (Hyp) and trace elements of bone so as to prevent and treat bone loss.
10.The different effects of D-galactose onbone histomorphometry in different gender rats
Hongmei LUO ; Liao CUI ; Tie WU
Chinese Pharmacological Bulletin 2003;0(10):-
Aim To study the effects of D-galactose o n bone of rats. Methods Forty-two Sprague-Dawley rats at age of 3 months with half female and half male were divided into five groups randoml y, basal, OVX or ORX , D-galactose at dose of 50 mg?kg -1?d -1 (L), D-galactose at dose of 100 mg?kg -1?d -1 (M), galactose a t dose of 200 mg?kg -1?d -1 (H).The former two groups were SC inject ed physiological saline and the latter three groups were injected three differen t doses of D-galactose respectively. Two months later the rats were killed by setting blood free from hearts, then the left thighbones and tibias were take n. The tibias were cut at 8 ?m sections for static and dynamic bone histomorph ometric analyses. The thighbones were dried and weighed. All rats were given sc injections of tetracycline 25 mg?kg -1 (first fluorochrome bone marker) on 14 and d 13,and calcein 10 mg?kg -1(second fluorochrome bone marker) on 4 and d 3 before sacrifice. The testicles and the ovaries were taken and made the paraffin slices for observing the microstructure under the microscope. Results D-galactose had no effects on bone of female rats, but can made male rats lose bone significantly and the rats appeared osteoporosis. The static parameters in three different dose male rats bone which relate to bone ma ss %Tb. Ar decreased 53.5%,53.5%,46.6% respectively, Tb.N decreased 42.9%,4 7.6%,38.1% respectively, TB.Sp increased 85%,150%,67.3% respectivly. The dynamic parameters which relate to bone formation %L. Pm decreased 24.1% 89.1% , 65.5% respectively. The convoluted suminiferous tubule disordered, lumens dil ated, and basal membrane disintegrated. Conclusion D-galac tose had different effects on bone of different gender rats. There is no effect on female bone, but it can induce the male rats osteoporosis. The mechanism of D-galactose on bone was probably due to the different effects on gonad glan ds.